Passage Bio, Inc. (PASG) Tops Q2 EPS by 5c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.26), $0.05 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• ​SpaceX plans to launch new AI model with Cursor - The Information
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance
• Investment Firm Eqt Seeks To Raise $2.5 Billion In Second Pan-asia, Mid-cap Buyout Fund, Sources Say - Reuters